Administration of the CTSB inhibitor CA-074me prior to pancreatitis induction in a rat model significantly reduced intrapancreatic trypsinogen activation.187 Although CA-074Me has been shown to significantly inhibit the enzymatic cascade, its clinical application in patients with AP remains limited. Here, CTSB is linked to pancreatitis.